Biodel (BIOD) Says Albireo Announces Positive Top-Line Phase 3 Results for Elobixibat in Japan
Tweet Send to a Friend
As previously announced, Biodel Inc. (Nasdaq: BIOD) has entered into an amended and restated share exchange agreement (the “Exchange Agreement”) ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
